Stephen P. James

发表

Use of Cytotoxic Agents and Cyclosporine in the Treatment of Autoimmune Disease: Part 2: Inflammatory Bowel Disease, Systemic Vasculitis, and Therapeutic Toxicity

S. James, J. Klippel, J. Balow, 1998, Annals of Internal Medicine.

Inflammatory Bowel Disease Mucosal Biopsies Have Specialized Lymphokine mRNA Profiles

G. Mullin, S. James, S. Katz, 1996, Inflammatory bowel diseases.

Effects of Japanese herbal medicine “Sho‐saiko‐to” on in vitro production of tumor necrosis factor‐alpha on peripheral blood mononuclear cells

T. Nakano, J. Klapproth, Qiaowei Zheng, 1994 .

Use of Cytotoxic Agents and Cyclosporine in the Treatment of Autoimmune Disease: Part 1: Rheumatologic and Renal Diseases

J. Klippel, J. Balow, M. Sneller, 1998, Annals of Internal Medicine.

Two‐color analysis of peripheral lymphocyte surface antigens in inherently healthy adults

S. James, Y. Kosaka, M. Yamashiki, 1994, Journal of clinical laboratory analysis.

Mixed Infection with cagA‐Positive and cagA‐Negative Strains of Helicobacter pylori

S. James, G. Fantry, P. Darwin, 1996, Helicobacter.

Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1.

J. Herman, M. Esteller, N. Harpaz, 2000, Cancer research.

Hypermethylation of the hMLH1 gene promoter in human gastric cancers with microsatellite instability.

J. Herman, M. Esteller, S. Powell, 1999, Cancer research.

Treatment of severe esophageal Crohn's disease with infliximab.

C. Drachenberg, S. James, T. Heller, 1999, Inflammatory bowel diseases.

Products of enteropathogenic Escherichia coli inhibit lymphocyte activation and lymphokine production

J. Abraham, H. Mobley, S. James, 1995, Infection and immunity.

Products of enteropathogenic E. coli inhibit lymphokine production by gastrointestinal lymphocytes.

J. Abraham, S. James, M. Donnenberg, 1996, The American journal of physiology.